Guangzhou Ambition (LBP) Pharmaceutical Technology Overview
- Year Founded
-
2005
- Status
-
Public
- Employees
-
768
- Stock Symbol
-
688393
- Investments
-
4
- Share Price
-
$2.65
- (As of Friday Closing)
Guangzhou Ambition (LBP) Pharmaceutical Technology General Information
Description
Guangzhou LBP Medicine Science & Technology Co Ltd is engaged in production and sales of in vitro diagnostic reagents and instruments. The company's products include Fluorescence in situ hybridization (FISH) series; Immunohistochemistry (IHC) series; Liquid - based cytology (LBP) series; PCR series; and medical laboratory.
Contact Information
Website
www.gzlbp.comCorporate Office
- Self-Made 7, Road number 11
- Nanxiang Three, Luogang District
- Guangzhou, Guangdong 510663
- China
Corporate Office
- Self-Made 7, Road number 11
- Nanxiang Three, Luogang District
- Guangzhou, Guangdong 510663
- China
Guangzhou Ambition (LBP) Pharmaceutical Technology Stock Performance
As of 13-Nov-2026, Guangzhou Ambition (LBP) Pharmaceutical Technology’s stock price is $2.65. Its current market cap is $248M with 93.6M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $2.65 | $2.74 | $2.32 - $5.59 | $248M | 93.6M | 2.08M | -$0.05 |
Guangzhou Ambition (LBP) Pharmaceutical Technology Financials Summary
As of 30-Sep-2026, Guangzhou Ambition (LBP) Pharmaceutical Technology has a trailing 12-month revenue of $51.7M.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 270,292 | 277,203 | 205,206 | 310,437 |
| Revenue | 51,669 | 47,897 | 65,611 | 70,290 |
| EBITDA | (5,672) | (2,338) | 5,807 | 7,047 |
| Net Income | (5,071) | (6,539) | 2,967 | 5,662 |
| Total Assets | 184,346 | 184,002 | 186,673 | 197,490 |
| Total Debt | 340 | 444 | 1,430 | 4,005 |
Guangzhou Ambition (LBP) Pharmaceutical Technology Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Guangzhou Ambition (LBP) Pharmaceutical Technology Signals
Guangzhou Ambition (LBP) Pharmaceutical Technology Investments (4)
Guangzhou Ambition (LBP) Pharmaceutical Technology’s most recent deal was a Corporate with Fangxin for . The deal was made on 01-Jun-2023.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Fangxin | 01-Jun-2023 | Corporate | Other Healthcare Technology Systems | ||
| ThunderBio | 23-Sep-2022 | Later Stage VC | Diagnostic Equipment | ||
| Gaugene | 01-Jul-2022 | Later Stage VC | Diagnostic Equipment | ||
| Targene Biotech | 10-Jun-2022 | Later Stage VC | Diagnostic Equipment |
Guangzhou Ambition (LBP) Pharmaceutical Technology ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Biotechnology
Subindustry
Rank
Percentile
Guangzhou Ambition (LBP) Pharmaceutical Technology FAQs
-
When was Guangzhou Ambition (LBP) Pharmaceutical Technology founded?
Guangzhou Ambition (LBP) Pharmaceutical Technology was founded in 2005.
-
Where is Guangzhou Ambition (LBP) Pharmaceutical Technology headquartered?
Guangzhou Ambition (LBP) Pharmaceutical Technology is headquartered in Guangzhou, China.
-
What is the size of Guangzhou Ambition (LBP) Pharmaceutical Technology?
Guangzhou Ambition (LBP) Pharmaceutical Technology has 768 total employees.
-
What industry is Guangzhou Ambition (LBP) Pharmaceutical Technology in?
Guangzhou Ambition (LBP) Pharmaceutical Technology’s primary industry is Diagnostic Equipment.
-
Is Guangzhou Ambition (LBP) Pharmaceutical Technology a private or public company?
Guangzhou Ambition (LBP) Pharmaceutical Technology is a Public company.
-
What is Guangzhou Ambition (LBP) Pharmaceutical Technology’s stock symbol?
The ticker symbol for Guangzhou Ambition (LBP) Pharmaceutical Technology is 688393.
-
What is the current stock price of Guangzhou Ambition (LBP) Pharmaceutical Technology?
As of 13-Nov-2026 the stock price of Guangzhou Ambition (LBP) Pharmaceutical Technology is $2.65.
-
What is the current market cap of Guangzhou Ambition (LBP) Pharmaceutical Technology?
The current market capitalization of Guangzhou Ambition (LBP) Pharmaceutical Technology is $248M.
-
What is Guangzhou Ambition (LBP) Pharmaceutical Technology’s current revenue?
The trailing twelve month revenue for Guangzhou Ambition (LBP) Pharmaceutical Technology is $51.7M.
-
What is Guangzhou Ambition (LBP) Pharmaceutical Technology’s annual earnings per share (EPS)?
Guangzhou Ambition (LBP) Pharmaceutical Technology’s EPS for 12 months was -$0.05.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process